Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia

Antioxidants and Redox Signaling

Volumn 20, Issue 15, 2014, Pages 2361-2371

  Jumbo Lucioni, Patricia P ^a,d   Ryan, Emily L ^a   Hopson, Marquise L ^a   Bishop, Heather M ^b   Weitner, Tin ^c   Tovmasyan, Artak ^c   Spasojevic, Ivan ^c   Batinic Haberle, Ines ^c   Liang, Yongliang ^a   Jones, Dean P ^a   Fridovich Keil, Judith L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GALACTOSE; GALACTOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HEXOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; MANGANESE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; METALLOPORPHYRIN; MN(III) MESO-TETRAKIS(N-N-BUTOXYETHYLPYRIDINIUM-2-YL)PORPHYRIN;

ARTICLE; DIET RESTRICTION; DROSOPHILA MELANOGASTER; GALACTOSEMIA; LARVA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; BLOOD; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GALACTOSEMIAS; GENETICS; MALE; METABOLISM; MOLECULAR MIMICRY; MORTALITY; OXIDATION REDUCTION REACTION;

ANIMALS; CYSTEINE; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; GALACTOSE; GALACTOSEMIAS; GLUTATHIONE; MALE; METABOLIC NETWORKS AND PATHWAYS; METALLOPORPHYRINS; MOLECULAR MIMICRY; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 84899712730     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5122     Document Type: Article

References (49)

1. Alias Z and Clark AG. Studies on the glutathione Stransferase proteome of adult Drosophila melanogaster: responsiveness to chemical challenge. Proteomics 7: 3618-3628, 2007.
2. Batinic-Haberle I, Rajic Z, Tovmasyan A, Reboucas J, Ye X, Leong K, Dewhirst M, Vujaskovic Z, Benov L, and Spasojevic I. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Free Radic Biol Med 51: 1035-1053, 2011.
3. Batinic-Haberle I, Reboucas J, and Spasojevic I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid Redox Signal 13: 877-918, 2010.
4. Batinic-Haberle I, Spasojevic I, Tse H, Tovmasyan A, Rajic Z, St Clair D, Vujaskovic Z, Dewhirst M, and Piganelli J. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino Acids 42: 95-113, 2012.
5. Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, and Segal S. Endogenous synthesis of galactose in normal men and patients with hereditary galactosemia. Lancet 346: 1073-1074, 1995.
6. Bonilla E, Medina-Leendertz S, Villalobos V, Molero L, and Bohórquez A. Paraquat-induced oxidative stress in Drosophila melanogaster: effects of melatonin, glutathione, serotonin, minocycline, lipoic acid and ascorbic acid. Neurochem Res 31: 1425-1432, 2006.
7. Bosch AM. Classical galactosaemia revisited. J Inherit Metab Dis 29: 516-525, 2006.
8. Bumrungpert A, Kalpravidh RW, Chuang C-C, Overman A, Martinez K, Kennedy A, and McIntosh M. Xanthones from mangosteen inhibit inflammation in human macrophages and in human adipocytes exposed tomacrophage-conditioned media. J Nutr 140: 842-847, 2010.
9. Cui X, Wang L, Zuo P, Han Z, Fang Z, Li W, and Liu J. DGalactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology 5: 317-325, 2004.
10. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, and Milzani A. Is there an answer? IUBMB Life 57: 189-192, 2005.
11. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, and Milzani A. S-glutathionylation in protein redox regulation. Free Radic Biol Med 43: 883-898, 2007.
12. Di Simplicio P, Franconi F, Frosalí S, and Di Giuseppe D. Thiolation and nitrosation of cysteines in biological fluids and cells. Amino Acids 25: 323-339, 2003.
13. Duarte TL, and Lunec J. Review part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression review: when is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C. Free Radic Res 39: 671-686, 2005.
14. Engerman RL, and Kern TS. Experimental galactosemia produces diabetic-like retinopathy. Diabetes 33: 97-100, 1984.
15. Ficicioglu C, Thomas N, Yager C, Gallagher PR, Hussa C, Mattie A, Day-Salvatore DL, and Forbes BJ. Duarte (DG) galactosemia: a pilot study of biochemical and neurodevelopmental assessment in children detected by newborn screening. Mol Genet Metab 95: 206-212, 2008.
16. Fridovich-Keil JL, and Walter JH. Galactosemia. In: The Online Metabolic and Molecular Bases of Inherited Disease, edited by Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, and Ballabio A. New York, NY: McGraw Hill, 2008 www.ommbid.com/
17. Go Y, and Jones D. Redox control systems in the nucleus: mechanisms and functions. Antioxid Redox Signal 13: 489-509, 2010.
18. Go Y, and Jones D. Thiol/disulfide redox states in signaling and sensing. Crit Rev Biochem Mol Biol 48: 173-181, 2013.
19. Hughes J, Ryan S, Lambert D, Geoghegan O, Clark A, Rogers Y, Hendroff U, Monavari A, Twomey E, and Treacy E. Outcomes of siblings with classical galactosemia. J Pediatr 154: 721-726, 2009.
20. Hyland K, and Auclair C. The formation of superoxide radical anions by a reaction between O2, OH- and dimethyl sulfoxide. Biochem Biophys Res Commun 102: 531-537, 1981.
21. Iciek M, Chwatko G, Lorenc-Koci E, Bald E, and Wlodek L. Plasma levels of total, free and protein bound thiols as well as sulfane sulfur in different age groups of rats. Acta Biochim Pol 51: 815-824, 2004.
22. Isselbacher KJ, Anderson EP, Kurahashi K, and Kalckar HM. Congenital galactosemia, a single enzyme block in galactose metabolism. Science 123: 635-636, 1956.
23. Jones D. Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879, 2006.
24. Jones DP, Carlson JL, Mody VC, Cai J, Lynn MJ, and Sternberg P. Redox state of glutathione in human plasma. Free Radic Biol Med 28: 625-635, 2000.
25. Jumbo-Lucioni P, Hopson M, Hang D, Liang Y, Jones D, and Fridovich-Keil J. Oxidative stress contributes to outcome severity in a Drosophila melanogaster model of classic galactosemia. Dis Model Mech 6: 84-94, 2012.
26. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, and Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 27: 1208-1218, 1999.
27. Kushner RF, Ryan EL, Sefton JM, Sanders RD, Lucioni PJ, Moberg KH, and Fridovich-Keil JL. A Drosophila melanogaster model of classic galactosemia. Dis Model Mech 3: 618-627, 2010.
28. This reference has been deleted.
29. Larson RT, Lorch JM, Pridgeon JW, Becnel JJ, Clark GG, and Lan Q. The biological activity of alpha-mangostin, a larvicidal botanic mosquito sterol carrier protein-2 inhibitor. J Med Entomol 47: 249-257, 2010.
30. Leslie ND, Yager KL, McNamara PD, and Segal S. A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med 59: 7-12, 1996.
31. Li HM, Buczkowski G, Mittapalli O, Xie J, Wu J, Westerman R, Schemerhorn BJ, Murdock LL, and Pittendrigh BR. Transcriptomic profiles of Drosophila melanogaster third instar larval midgut and responses to oxidative stress. Insect Mol Biol 17: 325-339, 2008.
32. Marroquin L, Hynes J, Dykens J, Jamieson J, and Will Y. Circumventing the crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97: 539-547, 2007.
33. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, and Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 1822: 794-814, 2012.
34. Ning C, Reynolds R, Chen J, Yager C, Berry GT, McNamara PD, Leslie N, and Segal S. Galactose metabolism by the mouse with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 48: 211-217, 2000.
35. Openo K, Schulz J, Vargas C, Orton C, Epstein M, Schnur R, Scaglia F, Berry G, Gottesman G, Ficicioglu C, Slonim A, Shroer R, Yu C, Rangel V, Kenan J, Lamance K, and Fridovich-Keil J. Epimerase-deficiency galactosemia is not a binary condition. Am J Hum Genet 78: 89-102, 2006.
36. Rajic Z, Tovmasyan A, Spasojevic I, Sheng H, Lu M, Li A, Gralla E, Warner D, Benov L, and Batinic-Haberle I. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity. Free Radic Biol Med 52: 1828-1834, 2012.
37. Rebrin I, Bayne A, Mockett R, Orr W, and Sohal R. Free aminothiols, glutathione redox state and protein mixed disulphides in aging Drosophila melanogaster. Biochem J 382: 131-136, 2004.
38. Repnikova E, Koles K, Nakamura M, Pitts J, Li H, Ambavane A, Zoran M, and Panin V. Sialyltransferase regulates nervous system function in Drosophila. J Neurosci 30: 6466-6476, 2010.
39. Rose RC, and Bode AM. Biology of free radical scavengers: an evaluation of ascorbate. FASEB J: official publication of the Federation of American Societies for Experimental Biology 7: 1135-1142, 1993.
40. Ross KL, Davis CN, and Fridovich-Keil JL. Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. Mol Genet Metab 83: 103-116, 2004.
41. Ryan E, Duboff B, Feany M, and Fridovich-Keil J. Mediators of a long-term movement abnormality in a Drosophila melanogaster model of classic galactosemia. Dis Model Mech 5: 796-803, 2012.
42. Schweitzer S, Shin Y, Jakobs C, and Brodehl J. Long-term outcome in 134 patients with galactosemia. Eur J Pediatr 152: 36-43, 1993.
43. Shen Y, Xu S, Wei W, Sun X, Yang J, Liu L, and Dong C. Melatonin reduces memory changes and neural oxidative damage in mice treated with D-galactose. J Pineal Res 32: 173-178, 2002.
44. Spasojevic I, Miryala S, Tovmasyan A, Salvemini D, Vujaskovic Z, Batinic-Haberle I, and St Clair D. Lipophilicity of Mn(III) N- alkylpyridylporphyrins dominates their accumulation within mitochondria and therefore in vivo efficacy. A mouse study. Free Radic Biol Med 51: S98, 2011.
45. Tang M, Odejinmi S, Vankayalapati H, Wierenga K, and Lai K. Innovative therapy for classic galactosemia: tale of two HTS. Mol Genet Metab Oct 2011 [Epub ahead of print].
46. Thannickal V, and Fanburg B. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
47. Truong T, and Carroll K. Redox regulation of protein kinases. Crit Rev Biochem Mol Biol May 3, 2013 [Epub ahead of print].
48. Walter JH, Collins JE, Leonard JV, Chiswick M, and Marcovitch H. Recommendations for the management of galactosaemia: commentary. Arch Dis Child 80: 93-96, 1999.
49. Weitner T, Sheng H, Miriyala S, Leu D, Tovmasyan A, Kos I, Reboucas J, Fan P, Vujaskovic Z, Batinic-Haberle I, Huang T, St Clair D, Warner D, and Spasojevic I. Comprehensive pharmocokinetic studies and biodistribution of two cationic Mn porphyrins-based catalysts, MnTE-2-PyP5+ and MnTnHex-2-PyP5+ : plasma and organ oral availability, mitochondrial, cytosolic, whole brain, hippocampus and cortex distribution. Free Radic Biol Med 53: S118, 2012.